{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:23:50Z","timestamp":1792639430544,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtm.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T21:28:56Z","timestamp":1630963736000},"page":"158-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-975X","authenticated-orcid":false,"given":"Qinglan","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-4362","authenticated-orcid":false,"given":"Matthew","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4329-506X","authenticated-orcid":false,"given":"MinJae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-8621","authenticated-orcid":false,"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.09.001_bib1","first-page":"1188","article-title":"Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings","volume":"24","author":"Rossi","year":"2003","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.omtm.2021.09.001_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: One disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2021.09.001_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/3804","article-title":"SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome","volume":"20","author":"Zhu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2021.09.001_bib4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1086\/302150","article-title":"Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency","volume":"63","author":"Tiranti","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2021.09.001_bib5","doi-asserted-by":"crossref","first-page":"25735","DOI":"10.1074\/jbc.M109.040295","article-title":"Surf1, associated with Leigh syndrome in humans, is a heme-binding protein in bacterial oxidase biogenesis","volume":"284","author":"Bundschuh","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.09.001_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbabio.2011.09.007","article-title":"Role of Surf1 in heme recruitment for bacterial COX biogenesis","volume":"1817","author":"Hannappel","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2021.09.001_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/hmg\/ddg038","article-title":"Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice","volume":"12","author":"Agostino","year":"2003","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.omtm.2021.09.001_bib8","first-page":"194","article-title":"Missense mutations in SURF1 associated with deficient cytochrome c oxidase assembly in Leigh syndrome patients","volume":"106","author":"Poyau","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtm.2021.09.001_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1750-1172-8-96","article-title":"SURF1 deficiency: A multi-centre natural history study","volume":"8","author":"Wedatilake","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2021.09.001_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1535676019899502","article-title":"Viral vector systems for gene therapy: A comprehensive literature review of progress and biosafety challenges","volume":"25","author":"Ghosh","year":"2020","journal-title":"Appl. Biosaf."},{"key":"10.1016\/j.omtm.2021.09.001_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd.2018.110","article-title":"Gene therapy for neurological disorders: Progress and prospects","volume":"17","author":"Deverman","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2021.09.001_bib12","doi-asserted-by":"crossref","first-page":"146832","DOI":"10.1016\/j.brainres.2020.146832","article-title":"Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies","volume":"1739","author":"Bailey","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2021.09.001_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/hum.2011.008","article-title":"Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery","volume":"22","author":"Snyder","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.omtm.2018.02.005","article-title":"Development of intrathecal AAV9 gene therapy for giant axonal neuropathy","volume":"9","author":"Bailey","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.09.001_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/hmg\/ddl477","article-title":"Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice","volume":"16","author":"Dell\u2019agnello","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.09.001_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20140291","article-title":"Complex IV-deficient Surf1\u2212\/\u2212 mice initiate mitochondrial stress responses","volume":"462","author":"Pulliam","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtm.2021.09.001_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","article-title":"In\u00a0vivo correction of COX deficiency by activation of the AMPK\/PGC-1\u03b1 axis","volume":"14","author":"Viscomi","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2021.09.001_bib21","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in\u00a0vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib23","doi-asserted-by":"crossref","first-page":"e12769","DOI":"10.1111\/acel.12769","article-title":"Lifelong reduction in complex IV induces tissue-specific metabolic effects but does not reduce lifespan or healthspan in mice","volume":"17","author":"Deepa","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.omtm.2021.09.001_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/gt.2017.53","article-title":"AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome","volume":"24","author":"Meo","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbadis.2016.01.007","article-title":"Tissue- and species-specific differences in cytochrome c oxidase assembly induced by SURF1 defects","volume":"1862","author":"Kov\u00e1\u0159ov\u00e1","year":"2016","journal-title":"Biochim. Biophys."},{"key":"10.1016\/j.omtm.2021.09.001_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awv357","article-title":"Loss of the smallest subunit of cytochrome c oxidase, COX8A, causes Leigh-like syndrome and epilepsy","volume":"139","author":"Hallmann","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2021.09.001_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/jcbfm.2013.116","article-title":"Decreased in\u00a0vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice","volume":"33","author":"Lin","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow Metab"},{"key":"10.1016\/j.omtm.2021.09.001_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cell.2020.02.051","article-title":"Mitochondrial diseases: Hope for the future","volume":"181","author":"Russell","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.09.001_bib29","series-title":"The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models","author":"Fox","year":"2006"},{"key":"10.1016\/j.omtm.2021.09.001_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/gt.2011.130","article-title":"Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs","volume":"19","author":"Federici","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.09.001_bib32","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Cl\u00e9ment","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.09.001_bib33","first-page":"4.17.11","article-title":"Production of recombinant adeno-associated viral vectors and use in in\u00a0vitro and in\u00a0vivo administration","volume":"57","author":"Gray","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.omtm.2021.09.001_bib34","first-page":"4.17.11","article-title":"Production of recombinant adeno-associated viral vectors and use in in\u00a0vitro and in\u00a0vivo administration","volume":"57","author":"Gray","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.omtm.2021.09.001_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nprot.2006.478","article-title":"Organelle isolation: Functional mitochondria from mouse liver, muscle and cultured fibroblasts","volume":"2","author":"Frezza","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2021.09.001_bib36","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nprot.2008.105","article-title":"Isolation of mitochondria from rat brain using Percoll density gradient centrifugation","volume":"3","author":"Sims","year":"2008","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:28:18Z","timestamp":1762421298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"alternative-id":["S2329050121001364"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.09.001","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}